Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Hsu

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Molecular Medicine|February 22, 2005
Application of transcriptome analysis to clinical pharmacology studiesBenjamin Hsu, Lisa Cass, William V Williams
Bioinformatics (Oxford, England)|November 27, 2020
Autoregressive modeling and diagnostics for qPCR amplificationBenjamin Hsu, Valeriia Sherina, Matthew N McCall
Proteins|December 14, 2005
The Histone Database: a comprehensive resource for histones and histone fold-containing proteinsLeonardo Mariño-Ramírez, Benjamin Hsu, Andreas D Baxevanis, et al.
Journal of Clinical Pharmacology|March 27, 2018
Confirmatory Population Pharmacokinetic Analysis for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin-6, in Patients With Moderately to Severely Active Rheumatoid ArthritisYan Xu, Chuanpu Hu, Yanli Zhuang, et al.
The Journal of Rheumatology|March 3, 2016
Serum Vascular Endothelial Growth Factor Levels Lack Predictive Value in Patients with Active Ankylosing Spondylitis Treated with GolimumabJürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
The Journal of Rheumatology|July 17, 2016
Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with GolimumabJürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
Annals of the Rheumatic Diseases|April 5, 2014
Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapyJosef S Smolen, Michael E Weinblatt, Shihong Sheng, et al.
Journal of Clinical Pharmacology|June 15, 2018
Exposure-Response Modeling Analyses for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin 6, in Patients With Moderately to Severely Active Rheumatoid ArthritisYan Xu, Chuanpu Hu, Yanli Zhuang, et al.
The Journal of Rheumatology|June 5, 2003
Ultrasonography for assessment of subcutaneous nodulesSelim Nalbant, Hector Corominas, Benjamin Hsu, et al.
RMD Open|December 20, 2018
Investigating sirukumab for rheumatoid arthritis: 2-year results from the phase III SIRROUND-D studyCarter Thorne, Tsutomu Takeuchi, George Athanasios Karpouzas, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Molecular Medicine|February 22, 2005
Application of transcriptome analysis to clinical pharmacology studiesBenjamin Hsu, Lisa Cass, William V Williams
Bioinformatics (Oxford, England)|November 27, 2020
Autoregressive modeling and diagnostics for qPCR amplificationBenjamin Hsu, Valeriia Sherina, Matthew N McCall
Proteins|December 14, 2005
The Histone Database: a comprehensive resource for histones and histone fold-containing proteinsLeonardo Mariño-Ramírez, Benjamin Hsu, Andreas D Baxevanis, et al.
Journal of Clinical Pharmacology|March 27, 2018
Confirmatory Population Pharmacokinetic Analysis for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin-6, in Patients With Moderately to Severely Active Rheumatoid ArthritisYan Xu, Chuanpu Hu, Yanli Zhuang, et al.
The Journal of Rheumatology|March 3, 2016
Serum Vascular Endothelial Growth Factor Levels Lack Predictive Value in Patients with Active Ankylosing Spondylitis Treated with GolimumabJürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
The Journal of Rheumatology|July 17, 2016
Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with GolimumabJürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
Annals of the Rheumatic Diseases|April 5, 2014
Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapyJosef S Smolen, Michael E Weinblatt, Shihong Sheng, et al.
Journal of Clinical Pharmacology|June 15, 2018
Exposure-Response Modeling Analyses for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin 6, in Patients With Moderately to Severely Active Rheumatoid ArthritisYan Xu, Chuanpu Hu, Yanli Zhuang, et al.
The Journal of Rheumatology|June 5, 2003
Ultrasonography for assessment of subcutaneous nodulesSelim Nalbant, Hector Corominas, Benjamin Hsu, et al.
RMD Open|December 20, 2018
Investigating sirukumab for rheumatoid arthritis: 2-year results from the phase III SIRROUND-D studyCarter Thorne, Tsutomu Takeuchi, George Athanasios Karpouzas, et al.
Pageof 5